We are what we repeatedly do. Excellence, then, is not an act, but a habit.

Up to 1.3B SpaceX shares unlocked on Thu 22 Oct, two trading days after Q3 results. It's set by a lock-up timetable in the prospectus: 911.5M in Aug, five 7% steps, then 28% now. Musk's 6.4B stay locked until 12 Jun 2027. Unlocked doesn't mean sold.

OpenAI raised $122B at a $730B pre-money valuation. Add the cash and it's $852B post-money. The new investors' slice is $122B / $852B, about 14.3%, not 16.7%. Now it's reportedly in talks at about $1.4T pre-money. Always ask: pre or post?

Nscale's investors valued it at $14.6B in March. Its NYSE IPO ask is about $30B, per Bloomberg. Now some investors say buyers will pay $16-19B. CoreWeave fell 25% last week. A private price isn't a public price until the market tests it.

Filed in June. Still secret. Anthropic's IPO could value it at up to $2 trillion, Reuters reports, but its S-1 is a confidential draft. Reuters saw 261 pages, about 80 on risk. Big investors got Q3 numbers on 14 Oct. The public S-1 must land 15 days before the roadshow.

$47 billion. Then zero. WeWork was once the most valuable US startup. In 2019 its IPO was pulled and a rescue valued it at under $8B. In June 2024 every old share was cancelled for nothing. Markdowns, illiquidity, dilution, lock-ups: that is private-share risk.

SpaceX priced at $135, closed day one at $160.95 and was around $165 by early October. Anthropic wants to match or beat that size. Full deep dive: youtube.com/watch?v=s827fltR… Not financial advice. Private company shares are high risk and illiquid.

Anthropic's run-rate: about $4B in July 2025, over $65B by late July 2026. Q3 revenue: $16.8B. Full deep dive: youtube.com/watch?v=s827fltR… Not financial advice. Private company shares are high risk and illiquid.

$90 billion and still no IPO. Anduril's staff can now sell at that price. But headlines price preferred shares, and one study found they averaged 48% above fair value. OpenAI did the same in August, buying back $7B from staff. That's a tender offer.

Anthropic showed Wall Street its latest numbers. Reports put a possible listing around $2 trillion. Full deep dive: youtube.com/watch?v=s827fltR… Not financial advice. Private company shares are high risk and illiquid.

The investors you'll never see on the cap table. In an SPV, many investors pool into one vehicle that counts as one shareholder. The twist: some are boxes inside boxes, with fees at each layer. What would you check first?

This $965B company has no stock ticker. Anthropic went from $380B to $965B in one private round, and the public can't buy until it lists. The twist: some companies never do. Which private company are you watching?

Anthropic: confidential S-1 filed, no IPO date, no ticker yet. On WLTH you can get in from $20, with Slices backed 1:1 by real Anthropic equity held in an SPV. Private-market investment. Capital is at risk and values can fall as well as rise. This is not investment advice.

Shield AI: $12.7B in March, now in talks at $20B+ (The Information). The Navy just added $150M for X-BAT, its AI-piloted jet. First flights due this year. The jet or the AI pilot, which matters more? Disclosure: I work at WLTH. Not financial advice.

. @sean_o Sprout is the greatest innovation i've seen this year sir. Hats off.

Playboy stock at 3am on a Sunday on ST0x. How it works: each token is a debt note from an issuer. $754M of token transfers in 30 days, +167% (RWA xyz). Will 24/7 stock trading go mainstream? Disclosure: I work at WLTH. Not financial advice. Tokenised stocks are high risk.

Nuvacore is six months old, has no product, and is raising hundreds of millions at a roughly $2.5B valuation, per Reuters. Co-founder Gerard Williams sold his last startup, Nuvia, to Qualcomm for $1.4B. Team or product, which matters more in a chip startup?

The CFTC wants Polymarket and Kalshi bets treated as swaps, putting them under its oversight rather than state gambling rules, per CoinDesk. The Supreme Court has been asked to settle it. Should Polymarket and Kalshi answer to one federal regulator or to each state?

Oratomic raised $475M in a Series B, lifting its valuation to $5.4B, per the WSJ. Universal Quantum raised over $100M in its Series A, per SiliconANGLE. Will neutral-atom or trapped-ion systems reach scale first?